Microsoft has launched a new venture, Microsoft Frontier Company, backed by $2.5 billion, to guide businesses in selecting and integrating ...

Medical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its...

Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...

Indian car sales surged over 24% in June, marking a strong third consecutive month of double-digit growth. This boom, fueled by tax cuts an...

India's economy shows robust growth in Q1 FY27, with GST collections soaring 13.9% to Rs 1.95 lakh crore in June. Car sales surged 24%, and...

Shares of Nike fell as investors raised alarms over the slow pace of recovery with CEO Elliott Hill at the helm for nearly two years. While...

Luxury carmakers Ferrari and BMW are embracing aluminium wiring, following Tesla and Chinese EV manufacturers. This significant industry sh...

Car manufacturers are scaling back discounts on budget-friendly hatchbacks and entry-level models, indicating a robust recovery in mass-mar...

The recent drop in crude oil prices is providing some relief from inflation worries. Yet, the unpredictable monsoon season poses a serious ...

Indian government bonds saw an early rise on Monday, buoyed by strong foreign investment and stable oil prices, which helped offset geopoli...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...

The Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Danish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...